Psychotropic medication in children: a study from the Netherlands

E Schirm1, H Tobi, J M Zito

  • 1Groningen Institute for Drug Exploration (GUIDE), University of Groningen, University Centre for Pharmacy, Section of Social Pharmacy and Pharmacoepidemiology, Groningen, The Netherlands.

Pediatrics
|August 3, 2001
PubMed

Insights

Psychotropic medication use in Dutch children is lower than in the US, but stimulant use is increasing. This rise in stimulant prescriptions mirrors trends seen in the United States, indicating a broader pattern.

Area of Science:

  • Pediatric pharmacology
  • Drug utilization studies
  • Child and adolescent psychiatry

Background:

  • Global concern exists regarding increased psychotropic agent use in children.
  • Existing research primarily originates from the US, often using data from the mid-1990s.
  • Few studies comprehensively document the use of diverse psychotropic agent types in pediatric populations.

Purpose of the Study:

  • To investigate psychotropic medication utilization in children and adolescents in the Netherlands.
  • To compare Dutch psychotropic drug use patterns with previously reported US figures.
  • To analyze trends in the use of specific psychotropic agent classes.

Main Methods:

  • A drug utilization study was conducted using computerized pharmacy dispensing records.
  • The study period spanned from 1995 to 1999.
  • The research focused on children aged 0 to 19 years in the northern Netherlands.

Main Results:

  • Stimulants were the most prevalent psychotropic agents (7.4/1000 in 1999), followed by hypnotics/anxiolytics (6.9/1000) and antidepressants (4.4/1000).
  • Prevalence of stimulant use significantly increased from 1.5/1000 in 1995 to 7.4/1000 in 1999.
  • Most children (vast majority) received only one psychotropic agent concurrently.

Conclusions:

  • The prevalence of stimulant use in the Netherlands is considerably lower than US figures from 1995 (28/1000).
  • Differences were observed in the use of other psychotropic agents and their combinations compared to US data.
  • The observed increase in Dutch stimulant use aligns with US trends, suggesting this is not a US-exclusive phenomenon.
Abstract

Related Concept Videos

Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...